Keratoacanthoma - Keratoakantoma
☆ AI Dermatology — Free Service
Germaniyaning 2022 yilgi Stiftung Warentest natijalariga ko'ra, iste'molchilarning ModelDermdan qoniqish darajasi pullik teletibbiyot maslahatlariga qaraganda bir oz pastroq bo'lgan.
Germaniyaning 2022 yilgi Stiftung Warentest natijalariga ko'ra, iste'molchilarning ModelDermdan qoniqish darajasi pullik teletibbiyot maslahatlariga qaraganda bir oz pastroq bo'lgan.
Oddiy keratoakantoma (Keratoacanthoma)
relevance score : -100.0%
ReferencesKeratoacanthoma (KA) tez o'sishi va o'z-o'zidan regressga tushishi bilan mashhur bo'lgan teri shishi. Bu odatda quyosh nuri ta'siriga duchor bo'lgan, keksa va ochiq teriga ega erkaklarda uchraydi. Eksizyon yoki Mohs mikrografik jarrohlik yordamida olib tashlash odatiy davolanish bo'lsa-da, boshqa turli davolash usullari ham mavjud.
Keratoacanthoma (KA) is a common cutaneous tumor characterized by rapid growth and possible spontaneous regression. It most commonly affects older, fair-skinned males with significantly sun damaged skin. Although surgical removal with excision or Mohs micrographic surgery remains the standard of therapy, there are many alternative therapeutic modalities that can be utilized.
Keratoacanthoma (KA) is a common cutaneous tumor characterized by rapid growth and possible spontaneous regression. It most commonly affects older, fair-skinned males with significantly sun damaged skin. Although surgical removal with excision or Mohs micrographic surgery remains the standard of therapy, there are many alternative therapeutic modalities that can be utilized.
Keratoacanthoma (KA) - past darajadagi o'sma bo'lib, u terining ma'lum bezlarida boshlanadi va mikroskop ostida squamous cell carcinoma (SCC) ga o'xshaydi. KA ni invaziv SCC shakli sifatida tasniflash kerakligi bo'yicha munozaralar davom etmoqda.
Keratoacanthoma (KA) is a comparatively common low-grade tumor that initiates in the pilo-sebaceous glands and pathologically mimics squamous cell carcinoma (SCC). Essentially, strong debates confirm classifying keratoacanthoma as a variant of invasive SCC. The clinical behavior of KA is hardly predictable and the differential diagnosis of keratoacanthoma and other conditions with keratoacanthoma-like pseudocarcinomatous epithelial hyperplasia is challenging, both clinically and histopathologically.
Keratoacanthoma (KA) is a comparatively common low-grade tumor that initiates in the pilo-sebaceous glands and pathologically mimics squamous cell carcinoma (SCC). Essentially, strong debates confirm classifying keratoacanthoma as a variant of invasive SCC. The clinical behavior of KA is hardly predictable and the differential diagnosis of keratoacanthoma and other conditions with keratoacanthoma-like pseudocarcinomatous epithelial hyperplasia is challenging, both clinically and histopathologically.
Cutaneous squamous cell carcinoma (cSCC) odamlarda, ayniqsa keksa odamlarda, saratonning ikkinchi eng keng tarqalgan turi hisoblanadi. Jarrohlik odatda cSCCni davolash uchun qo'llaniladi, ammo jarrohlik qilolmaydigan yoki qilmaslikni tanlagan ba'zi bemorlar uchun intralezyonal davolash kabi boshqa variantlar ko'rib chiqilishi mumkin. An'anaviy intralezyonal davolash usullari (methotrexate yoki 5-fluorouracil) qo'llanilgan, ammo intralezyonal immunoterapiya va onkolitik viroterapiya kabi yangi yondashuvlar bo'yicha tadqiqotlar davom etmoqda. Bu yerda biz cSCC uchun klassik usullardan eng zamonaviy strategiyalargacha bo'lgan turli intralezyonal davolash usullarini ko'rib chiqamiz.
Cutaneous squamous cell carcinoma (cSCC) is the second most frequent cancer in humans, and it is especially common in fragile, elderly people. Surgery is the standard treatment for cSCC but intralesional treatments can be an alternative in those patients who are either not candidates or refuse to undergo surgery. Classic intralesional treatments, including methotrexate or 5-fluorouracil, have been implemented, but there is now a landscape of active research to incorporate intralesional immunotherapy and oncolytic virotherapy into the scene, which might change the way we deal with cSCC in the future. In this review, we focus on intralesional treatments for cSCC (including keratoacanthoma), from classic to very novel strategies.
Cutaneous squamous cell carcinoma (cSCC) is the second most frequent cancer in humans, and it is especially common in fragile, elderly people. Surgery is the standard treatment for cSCC but intralesional treatments can be an alternative in those patients who are either not candidates or refuse to undergo surgery. Classic intralesional treatments, including methotrexate or 5-fluorouracil, have been implemented, but there is now a landscape of active research to incorporate intralesional immunotherapy and oncolytic virotherapy into the scene, which might change the way we deal with cSCC in the future. In this review, we focus on intralesional treatments for cSCC (including keratoacanthoma), from classic to very novel strategies.
Mikroskop ostida Keratoakantoma (Keratoacanthoma) skuamoz hujayrali karsinomaga juda o'xshaydi. Ba'zi patologlar Keratoakantoma (Keratoacanthoma) ni xavfli o'simta emas, balki alohida ob'ekt sifatida tasniflashsa‑da, klinik va gistologik jihatdan uning taxminan 6 % invaziv va agressiv skuamoz hujayrali saratonga o'tadi.
○ Diagnoz va davolash
#Dermoscopy
#Skin biopsy